Compound cornel mix medicament for treating menorrhalgia

Abstract

The present invention relates to the field of medicine formulation, in particular to a compound evodia rutaecarpa mixture used to treat dysmenorrhea. The compound evodia rutaecarpa mixture adopts medcinal evodia fruit, turmeric root-tuber, safflower, nutgrass galingale rhizome, Chinese angelica, red paeony root, angelica dahurica, szechuan lovage rhizome, rhizoma corydalis, cassia barkcassia bark, frankincense and myrrh as materials, which are baked and then pulverized to prepare the compound evodia rutaecarpa mixture. The weight percentages of the materials are as follows: 15 percent to 18 percent of medcinal evodia fruit, 5 percent to 7 percent of turmeric root-tuber, 10 percent to 12 percent of safflower, 4 percent to 6 percent of nutgrass galingale rhizome, 10 percent to 13 percent of Chinese angelica, 10 percent to 12 percent of red paeony root, 3 percent to 5 percent of angelica dahurica, 10 percent to 12 percent of szechuan lovage rhizome, 5 percent to 7 percent of rhizoma corydalis, 3 percent to 5 percent of cassia barkcassia bark, 5 percent to 7 percent of frankincense and 3 percent to 5 percent of myrrh. The cost of the materials of the compound evodia rutaecarpa mixture for curing dysmenorrhea is low, the curative effect of the compound evodia rutaecarpa mixture is high in curing primary dysmenorrhea, and the compound evodia rutaecarpa mixture has no toxic side effects.

Description

technical field [0001] The invention relates to a Chinese patent medicine preparation, in particular to a compound evodia rutaecarpa mixed medicine for treating dysmenorrhea. Background technique [0002] As we all know, dysmenorrhea is one of the most common symptoms in gynecology. It refers to lower abdominal pain before and after menstruation or during menstruation, accompanied by backache or other discomfort, and even severe pain and fainting, which seriously affects the quality of life and work. Dysmenorrhea can be divided into two categories: primary and secondary. The former refers to dysmenorrhea without organic lesions in the reproductive organs, and the latter refers to dysmenorrhea caused by pelvic organic diseases. This prescription is mainly used to treat primary dysmenorrhea. Primary dysmenorrhea is more common in young women. According to the theory of traditional Chinese medicine, there are four main causes of primary dysmenorrhea. One is stagnation of Qi an...

AI Technical Summary

Problems solved by technology

Prostate synthetase inhibitors are used to prevent excessive or spastic uterine contractions by inhibiting prostate synthetase, such as ibuprofen, ketoprofen, fenac, etc., but the symptoms are not cured, and dysmenorrhea cannot be controlled, resulting in many Intramuscular injection of pethedine and other narcotic drugs for women with dysmenorrhea, which seriously affects their health

Images